In situ hybridization is a
technique used to label complementary DNA, RNA, or modified nucleic acids
strand. The technique helps to localize specific DNA or RNA sequence in the
small cross-section of tissues or an entire tissue. Hybridization technique is
used frequently for location of specific nucleic acid sequences on chromosomes
or in tissues for understanding the organization, regulation, and function of
gene.
Read Report Overview
- https://www.transparencymarketresearch.com/in-situ-hybridization-market.html
The in situ hybridization
technique expand the capabilities to satisfy any therapy needs and enable a new
diagnostic, treatment applications for the patients suffering from cancer or
other chronic diseases. Its unique technology in rapid detection of
aneuploidies during prenatal stage ensure better functional ability for
detecting abnormalities related to birth defects or mental disorders. However,
inability of probes to detect targeted sequences after few repeats can lead to
use of insufficient probes in few regions. This is likely to restrain growth of
in situ hybridization technique in laboratories.
High prevalence of diseases such
as cancer, Alzheimer’s disease, and other chronic diseases, rise in patient
awareness, surge in pharmacodynamics studies, and increase in diagnostic
centers for treatment procedures drive the global in situ hybridization market.
According to the American Association of Immunologists, Inc., an article
published in 2014 stated that scientists are profiling T-cell activation using
in situ hybridization technique and flow cytometry which will help to detect
the culturing technique of pathogens and their amplification methods. These
initiatives by associations and government funding is also likely to propel the
hybridization technique in the near future. In 2016, the National Cancer
Institute of the U.S. estimated that 1,685,210 new cases of cancer were
diagnosed in the U.S. and 595,690 people will die of the disease.
Request Brochure of
Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=56169
According to statistics of
National Cancer Institute, in 2012, there were 14 million new cases of cancer
and 8.2 million cancer-related deaths across the world. The number of new
cancer cases is likely to rise to 22 million within the next two decades.
Incidence of cancer can be reduced through early detection of disease and
management of patients who develop symptoms related to the disease.
Increase in number of patients
with cancer and different types of chronic diseases and rapidly rising
awareness about detection techniques are projected to fuel the growth of the in
situ hybridization market. However, high cost of probes, low detection ability
of FISH (fluorescence in situ hybridization) for major abnormalities of
patients, and significant time taken by the detection procedures are expected
to hamper the in situ hybridization market.
The global in situ hybridization
market can be segmented based on application, technology, end-user, and region.
In terms of application, the in situ hybridization market can be classified
into cancer diagnosis, immunology, cytology, neuroscience and infectious
diseases, and others. In terms of technology, the in situ hybridization market
can be segregated into fluorescence in situ hybridization (FISH), chromogenic
in situ hybridization, and others. Chromogenic in situ hybridization is a
rapidly expanding segment owing to the increase in use of technique in
diagnostic laboratories globally.
Request for Custom
Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=56169
In terms of end-user, the global
in situ hybridization market can be divided into diagnostic laboratories,
pathology labs, hospitals, clinics, and others. Diagnostic laboratories are
increasing its revenue due to increase in number of diagnosis of infectious
diseases following the environmental changes, and rise in prenatal test for
disease identification. These factors are likely to drive the segment during
the forecast period.
In terms of region, the global in
situ hybridization market can be segmented into North America, Latin America,
Europe, Asia Pacific, and Middle East & Africa. North America dominates the
global in situ hybridization market due to increase in funding for the
development of research and health care infrastructure and rise in biomedical
research activities. Surge in incidence of chronic diseases and cancer and increase
in demand for companion diagnostics drive the market in the U.S. This in turn
is expected to boost the in situ hybridization market in North America.
Pre Book In Situ
Hybridization Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=56169<ype=S
Europe is the second largest
market for in situ hybridization due to favorable government policies regarding
the development of health care infrastructure and molecular diagnostic
companies engaged in hybridization technique. The market in Asia Pacific is
expected to expand at a high growth rate during the forecast period due to
increase in cancer prevalence and diagnosis, changing lifestyle, rise in
awareness among patients, and surge in per capita expenditure. Additionally,
economic growth in India, China, and the Philippines supports the health care
infrastructure as well as expansion of biotechnology companies and pharma labs.
This is expected to fuel the growth of the market in Asia Pacific.
Major players operating in the
global in situ hybridization market include Abbott, Thermo Fisher Scientific,
Inc., Merck KGaA, Advanced Cell Diagnostics, Inc., F. Hoffmann-La Roche AG,
Agilent Technologies, BioGenex Laboratories, Inc., and Exiqon A/S.
About Us
Transparency Market Research is a
global market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for several decision makers.
Our experienced team of analysts, researchers, and consultants use proprietary
data sources and various tools and techniques to gather and analyze
information.
Our data repository is continuously
updated and revised by a team of research experts so that it always reflects
latest trends and information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary research
techniques in developing distinctive data sets and research material for
business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free:
866-552-3453
